Wellington Management Group LLP boosted its stake in Sinovac Biotech Ltd. (NASDAQ:SVA) by 0.4% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 5,252,235 shares of the biopharmaceutical company’s stock after buying an additional 22,814 shares during the period. Wellington Management Group LLP owned 9.31% of Sinovac Biotech worth $33,562,000 at the end of the most recent quarter.
Separately, OMERS ADMINISTRATION Corp purchased a new position in Sinovac Biotech during the first quarter valued at approximately $216,000.
Sinovac Biotech Ltd. (NASDAQ:SVA) traded up 0.34% during trading on Wednesday, hitting $5.88. 22,000 shares of the company’s stock traded hands. Sinovac Biotech Ltd. has a 12 month low of $4.38 and a 12 month high of $7.16. The stock has a market cap of $334.62 million and a P/E ratio of 140.00. The company’s 50 day moving average is $5.90 and its 200-day moving average is $6.07.
Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and H1N1 pandemic influenza and mumps, as well as animal rabies.
